Literature DB >> 5001955

Treatment of obsessional illnesses and phobic anxiety states with clomipramine.

W K Marshall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5001955     DOI: 10.1192/bjp.119.551.467

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  4 in total

1.  Agranulocytosis and systemic candidiasis following clomipramine therapy.

Authors:  R L Souhami; C R Ashton; J P Lee-Potter
Journal:  Postgrad Med J       Date:  1976-07       Impact factor: 2.401

2.  The assessment of drugs in obsessional states.

Authors:  R Philpott
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 3.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

4.  Mass fragmentographic analysis of clomipramine and its mono-demethylated metabolite in human plasma.

Authors:  G Alfredsson; F A Wiesel; B Fyro; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1977-03-23       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.